Year: 2026
Type: article
Abstract: Persistent ground-glass nodules (GGNs) can harbor early lung adenocarcinoma, yet similar computed tomography (CT) appearances may conceal distinct biological states. This narrative review integrates human genomic, single-cell, spatial, proteomic, and metabolomic evidence on immune and metabolic remodeling in GGN-associated disease. Reported alterations involve T-cell function and clonality, macrophage states, immune organization, and central-carbon, amino-acid, lipid, mitochondrial, and redox pathways. Nutrient availability, lactate, hypoxia, adenosine, and mitochondrial stress provide plausible connections, although causal support derives largely from experimental tumor models. Most human studies analyze resected lesions cross-sectionally, leaving their relationship to future radiological progression unresolved. We distinguish CT-defined GGN observations, histology-defined early adenocarcinoma evidence, and mechanistic extrapolation, and consider their implications for malignancy classification, progression prediction, and management decision support. Longitudinal studies combining standardized CT, repeated blood sampling, and clinically indicated spatially registered tissue are needed to test incremental value beyond established clinical and imaging predictors. Circulating signals require patient-level interpretation, whereas GGN growth is assessed per lesion. Immunometabolic profiling currently provides a research framework for biological risk assessment and requires prospective validation before informing surveillance decisions.
Source: Frontiers in Immunology
Institution: Fujian University of Traditional Chinese Medicine
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: ground-glass nodules, lung adenocarcinoma, immunometabolism, metabolic remodeling, T cell clonality, macrophage polarization, tumor microenvironment, mitochondrial stress, redox metabolism, hypoxia, lactate, adenosine, amino acid metabolism, lipid metabolism, progression prediction, malignancy classification, lung cancer surveillance, circulating biomarkers
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7236730957
